Beijing Kingee Culture Development Co., Ltd. (002721.SZ)
CNY 2.73
(0.74%)
CNY 2.73
(0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | -72.35% |
| 2022 | -2.52 Billion CNY | 15.51% |
| 2021 | -995.61 Million CNY | -135.48% |
| 2020 | -2.36 Billion CNY | -111.33% |
| 2019 | 718.37 Million CNY | 5.21% |
| 2018 | 553.96 Million CNY | -25.27% |
| 2017 | 925.82 Million CNY | 30.9% |
| 2016 | 752.44 Million CNY | 58.8% |
| 2015 | 462.04 Million CNY | 129.76% |
| 2014 | 202.89 Million CNY | -13.54% |
| 2013 | 227.42 Million CNY | 48.72% |
| 2012 | 154.72 Million CNY | 29.79% |
| 2011 | 124.88 Million CNY | 70.59% |
| 2010 | 72.96 Million CNY | 211.8% |
| 2009 | 23.64 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.29 Million CNY | -99.35% |
| 2024 Q2 | -6.48 Million CNY | -194.44% |
| 2024 Q3 | 3.75 Million CNY | 151.71% |
| 2023 FY | - CNY | -72.35% |
| 2023 Q3 | -43.9 Million CNY | 34.01% |
| 2023 Q2 | -66.53 Million CNY | -62.19% |
| 2023 Q1 | -41.02 Million CNY | 53.37% |
| 2023 Q4 | -235.38 Million CNY | -436.14% |
| 2022 Q2 | -70.42 Million CNY | -159.62% |
| 2022 Q4 | -87.97 Million CNY | -75.0% |
| 2022 FY | - CNY | 15.51% |
| 2022 Q3 | -50.26 Million CNY | 28.62% |
| 2022 Q1 | -27.12 Million CNY | 86.12% |
| 2021 Q4 | -195.46 Million CNY | -340.38% |
| 2021 Q3 | -44.38 Million CNY | 19.65% |
| 2021 Q2 | -55.24 Million CNY | -375.5% |
| 2021 FY | - CNY | -135.48% |
| 2021 Q1 | 20.05 Million CNY | 133.21% |
| 2020 Q2 | -52.11 Million CNY | -243.64% |
| 2020 FY | - CNY | -111.33% |
| 2020 Q4 | -60.37 Million CNY | -4.06% |
| 2020 Q3 | -58.02 Million CNY | -11.33% |
| 2020 Q1 | 36.28 Million CNY | -81.51% |
| 2019 FY | - CNY | 5.21% |
| 2019 Q2 | 155.21 Million CNY | -35.72% |
| 2019 Q3 | 154.2 Million CNY | -0.65% |
| 2019 Q1 | 241.45 Million CNY | -19.52% |
| 2019 Q4 | 196.27 Million CNY | 27.28% |
| 2018 Q2 | 116.27 Million CNY | -62.46% |
| 2018 Q4 | 300.01 Million CNY | 1776.09% |
| 2018 FY | - CNY | -25.27% |
| 2018 Q1 | 309.72 Million CNY | -30.19% |
| 2018 Q3 | -17.89 Million CNY | -115.39% |
| 2017 Q3 | 241.22 Million CNY | 17.38% |
| 2017 FY | - CNY | 30.9% |
| 2017 Q2 | 205.51 Million CNY | 147.52% |
| 2017 Q1 | 83.03 Million CNY | 308.58% |
| 2017 Q4 | 443.67 Million CNY | 83.92% |
| 2016 FY | - CNY | 58.8% |
| 2016 Q2 | -83.77 Million CNY | -125.9% |
| 2016 Q3 | 153.99 Million CNY | 283.82% |
| 2016 Q4 | -39.8 Million CNY | -125.85% |
| 2016 Q1 | 323.44 Million CNY | 65.67% |
| 2015 Q4 | 195.23 Million CNY | 135.8% |
| 2015 Q2 | 156.43 Million CNY | 311.9% |
| 2015 FY | - CNY | 129.76% |
| 2015 Q1 | 37.97 Million CNY | 105.77% |
| 2015 Q3 | 82.79 Million CNY | -47.07% |
| 2014 Q4 | 18.45 Million CNY | 185.55% |
| 2014 Q2 | -60.51 Million CNY | -150.28% |
| 2014 Q1 | 120.34 Million CNY | -25.9% |
| 2014 Q3 | -21.57 Million CNY | 64.35% |
| 2014 FY | - CNY | -13.54% |
| 2013 Q2 | 141.85 Million CNY | 187.21% |
| 2013 Q3 | 72.95 Million CNY | -48.57% |
| 2013 Q4 | 162.42 Million CNY | 122.63% |
| 2013 FY | - CNY | 48.72% |
| 2013 Q1 | 49.39 Million CNY | -1.8% |
| 2012 Q3 | 73.08 Million CNY | 0.0% |
| 2012 Q4 | 50.29 Million CNY | -31.18% |
| 2012 FY | - CNY | 29.79% |
| 2011 FY | - CNY | 70.59% |
| 2010 FY | - CNY | 211.8% |
| 2009 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chow Tai Seng Jewellery Co., Ltd. | 1.79 Billion CNY | 43.297% |
| Guangdong Chj Industry Co.,Ltd. | 532.37 Million CNY | -91.022% |
| Innovation Medical Management Co., Ltd. | 75.34 Million CNY | -1249.815% |